Badiu Iuliana, Nicola Stefania, Rashidy Nicolò, Della Mura Stefano, Tarrini Daniele, Bernardi Virginia, Gallicchio Mara, Ridolfi Irene, Saracco Elena, Montabone Erika, Mazzola Marina, Lo Sardo Luca, Geronazzo Giada, Comola Ludovica, Apricena Antonietta, Vitali Ilaria, Quinternetto Anna, Alessi Lucrezia, Meli Federico, Boem Marzia, Teocchi Marcelo, Schinocca Salvatore, Azzolina Maria Carmen Rita, Corradi Federica, Negrini Simone, Rolla Giovanni, Borrelli Richard, Brussino Luisa
Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.
Health Management, Mauriziano Hospital, 10128, Turin, Italy.
J Epidemiol Glob Health. 2024 Dec;14(4):1764-1770. doi: 10.1007/s44197-024-00309-2. Epub 2024 Oct 14.
The anti-COVID vaccination campaign has led to a significant increase in the demand for allergology consultations in patients considered at risk of reaction to anti-COVID-19 vaccines. This study aims to describe the experience of the vaccination campaign held in Piedmont (Italy) which developed a new service of Allergy Call Center (ACC) thus providing for the screening and management of allergy high-risk patients during pandemic.
A retrospective analysis was performed on all patients considered at high risk for the development of allergic reactions who were referred by the Immunology and Allergy Unit of Azienda Ospedaliera Ordine Mauriziano in Turin, Italy, between December 2020 and December 2022 and also on ACC consultations.
During the COVID-19 pandemic, Piedmont Region instituted the ACC, active from May 10th, 2021 to December 31st 2022, to allow vaccinating doctors to require a telephonic consultation for patients who were considered at high risk for the development of allergic reactions. If further diagnostic evaluations were required, the ACC scheduled a visit with a Consultant of the Unit to better assess the clinical situation of the patient. Furthermore, patients referred by General Practitioners, Occupational Doctors and other consultants were also evaluated by the Unit when required.
During the operational period the ACC received a total of 15,865 calls and referred only 336 patients to the unit (27.4% of the total referrals), while General Practitioners referred 499 patients (40.8%), Occupational Doctors referred 61 patients (4.9%), and other consultants referred 326 patients (26.6%).
Evaluation and management of a large volume of requests seemed to be facilitated by a proactive framework for screening patients at high risk for allergic reactions as the ones referred by our ACC. This approach led to a prominent decrease in allergological visits to our tertiary care Centre, reducing the waiting times and providing additional support for both patients and healthcare providers, thus allowing the vaccinations to be more easily handled.
抗新冠疫苗接种运动使得被认为有抗新冠病毒疫苗反应风险的患者对过敏科会诊的需求显著增加。本研究旨在描述在意大利皮埃蒙特开展的疫苗接种运动的经验，该运动开发了过敏呼叫中心（ACC）新服务，从而在大流行期间对过敏高风险患者进行筛查和管理。
对2020年12月至2022年12月期间由意大利都灵奥尔多·毛里齐亚诺医院免疫与过敏科转诊的所有被认为有发生过敏反应高风险的患者以及ACC会诊进行回顾性分析。
在新冠疫情期间，皮埃蒙特地区设立了ACC，于2021年5月10日至2022年12月31日期间运行，以便接种医生能够为被认为有发生过敏反应高风险的患者进行电话会诊。如果需要进一步的诊断评估，ACC会安排与该科室的顾问进行会诊，以更好地评估患者的临床情况。此外，全科医生、职业医生和其他顾问转诊的患者在需要时也会由该科室进行评估。
在运营期间，ACC共接到15865个电话，仅将336名患者转诊至该科室（占总转诊人数的27.4%），而全科医生转诊了499名患者（40.8%），职业医生转诊了61名患者（4.9%），其他顾问转诊了326名患者（26.6%）。
一个用于筛查像我们ACC转诊的过敏反应高风险患者的积极框架似乎有助于对大量请求进行评估和管理。这种方法导致我们三级护理中心的过敏科就诊显著减少，减少了等待时间，并为患者和医疗服务提供者提供了额外支持，从而使疫苗接种更容易进行。
